After opening the day in green, share markets in India have traded on a volatile note and are presently trading below the dotted line. Sectoral indices are trading mixed with stocks in the metal sector and stocks in the consumer durables sector trading in the red. While stocks in the pharma sector are trading in green.

The BSE Sensex is down by 8 points (down 0.1%) and the NSE Nifty is trading down by 10 points (down 0.1%). Meanwhile, the BSE Mid Cap index is trading up by 0.4%, while the BSE Small Cap index is trading up by 0.9%. The rupee is trading at 72.28 to the US$.

In news from stocks in the pharma sector. Dr. Reddy's Lab share price is in focus today after the company entered into a definitive agreement for the sale of its API manufacturing business unit located in Jeedimetla, Hyderabad.

The drugmaker sold the unit to Therapiva in a slump sale that included unit's fixed assets (land and building), current assets, current liabilities, and its employees.

Therapiva a generics manufacturer is a joint venture between Omnicare Drugs India Private Limited, a wholly owned subsidiary of Neopharma LLC, Abu Dhabi and Laxai Life Sciences Private Ltd.

At the time of writing, Dr. Reddy's share price was trading up by 4%.

Speaking of pharma stocks. The healthcare index seems to have weathered the storm in the Indian markets.

Pharma and IT Outshine Their Peers

Moving on to news from stocks in the engineering sector. Larsen & Toubro (L&T) share price is in focus today as the company bagged major orders.

L&T said that its heavy engineering arm bagged additional orders worth over Rs 10 billion during the September quarter.

The orders include three super heavy hydrocracking reactors for an Indian refinery to be built for the first time in the world. The total order inflow in H1 FY19 for the process plant and nuclear equipment business of heavy engineering reached Rs 26.6 billion.

At the time of writing, L&T share price was trading down by 1.5%.